Consonance HFW

YTD

ALL

Why Robinhood?

You can watch Consonance HFW and buy or sell other stocks, ETFs, and their options commission-free!

About CHFW

Surrozen, Inc. is a clinical stage biotechnology company, which engages in the business of discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. The company was founded by K.

CEO

Craig C. Parker, MBA

CEOCraig C. Parker, MBA

Employees

Employees41

Headquarters

South San Francisco, California

HeadquartersSouth San Francisco, California

Founded

2015

Founded2015

Employees

Employees41

CHFW Key Statistics

Market cap

31.93M

Market cap31.93M

Price-Earnings ratio

-0.47

Price-Earnings ratio-0.47

Dividend yield

—

Dividend yield—

Average volume

11.49K

Average volume11.49K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$18.17

52 Week high$18.17

52 Week low

$6.00

52 Week low$6.00

Consonance HFW

Why Robinhood?

Surrozen, Inc. is a clinical stage biotechnology company, which engages in the business of discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. The company was founded by K. Show more

CHFW Key Statistics

Surrozen, Inc. is a clinical stage biotechnology company, which engages in the business of discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. The company was founded by K.